Source:http://linkedlifedata.com/resource/pubmed/id/20967857
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2011-1-4
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
1529-0131
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
63
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
305; author reply 305
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al.
|
| pubmed:publicationType |
Letter,
Comment
|